Stay updated on Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.

Latest updates to the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice announces a transition in NIH content from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes to v3.7.2. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe study record page is replaced by a 403 error page, with a minimal header showing '403 Forbidden' and a Home button, and the previously visible study content has been hidden. This indicates an access restriction or site outage preventing retrieval of the study information.SummaryDifference17%

- Check37 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0 to reflect a recent deployment. This is a maintenance/versioning update that does not modify study details or page content.SummaryDifference0.0%

- Check51 days agoChange DetectedA newer revision (v3.6.6) was published, replacing the previous version (v3.6.5). This appears to be a maintenance/release update with no substantive changes to the study details.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page's revision tag was updated to v3.6.5, indicating a newer version of the study record.SummaryDifference0.0%

Stay in the know with updates to Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.